1) relapsed small cell lung cancer
复发性小细胞肺癌
1.
Effect of IP as second-line chemotherapy for patients with relapsed small cell lung cancer
IP方案二线治疗复发性小细胞肺癌的临床观察
2) non-small cell lung cancer
原发性非小细胞肺癌
1.
Objective To discuss the effect of three-dimmentional conformal radiotherapy on non-small cell lung cancer in the elderly.
目的观察适形放射治疗在老年原发性非小细胞肺癌中的治疗效果。
3) non-small cell lung cancer
非小细胞性肺癌
1.
The in situ analysis of cytokine mRNA expression in immunological microenvironment about non-small cell lung cancer;
非小细胞性肺癌局部免疫微环境中细胞因子mRNA表达的分析
2.
Objective To investigate the normal range of serum CYFRA21-1 levels in local sabjects and the lower limit for the establishment of diagnosis in patients with non-small cell lung cancer.
方法:采用免疫放射分 析,分析了90例健康人和58例肺良性疾病及42例非小细胞性肺癌患者血清CYFRA21-1的含量。
4) NSCLC
非小细胞性肺癌
1.
Objectives:Lung cancer includes non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
目的:肺癌可分为非小细胞性肺癌(NSCLC)和小细胞性肺癌(SCLC)。
2.
Objective:To analyze the aberrant promoter hypermethylation of Runx3 gene in human non-small cell lung carcinoma(NSCLC).
目的:分析非小细胞性肺癌(NSCLC)中Runx3基因启动子区甲基化状态。
5) Small cell lung cancer
小细胞肺癌
1.
Combination chemotherapy with irinotecan and cisplatin as second-line treatment for small cell lung cancer;
依立替康联合顺铂二线治疗小细胞肺癌
2.
Radio-chemotherapy for patients with limited-stage small cell lung cancer;
局限期小细胞肺癌的放化疗
3.
Relation between the level of TPS,NSE,CEA and β_2-mG in the serum and the biological behavior of small cell lung cancer;
血清TPS、NSE、CEA、β_2MG水平与小细胞肺癌生物学关系的探讨
6) SCLC
小细胞肺癌
1.
Abnormal Methylation of Mismatch Repair Genes MLH1 and MSH2 in Human SCLC Cell Line H446 under Hypoxic Condition;
缺氧状态下人小细胞肺癌H446细胞错配修复基因MLH1、MSH2异常甲基化的研究
2.
Objective The aim of this study is to evaluate the efficacy and safety of the irinotecan and cisplatin combination in relapsed advanced SCLC.
目的观察伊立替康联合顺铂方案治疗复治性晚期小细胞肺癌的疗效和安全性。
3.
Aim To evaluate the therapeutic efficiency of Ad-hTRAIL (the replication-defective adenovirus expressing recombinant human TRAIL gene) on human small cell lung cancer (SCLC) cell line H446 in vitro.
目的评价携带人TRAIL基因的腺病毒载体对人小细胞肺癌细胞株H446的基因治疗功效。
补充资料：复发
复发
〖HT5”SS〗relapse
已经好转的疾病或已经消失的症状，经过一段时间后再度发生。主要是因为机体内原来的病因尚未完全消除，机体抗病能力再度下降，使体内病原体又复活跃，症状再度出现。因此对疾病应积极进行彻底治疗和加强机体抵抗力。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条